Khara Rahul sold $188K of IRON
Khara Rahul (Chief Legal Officer) sold 2,500 shares of Disc Medicine, Inc. (IRON) at $75.00 ($0.19M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider trading record with exact sale dates, share count, and total value, but does not introduce new operational, clinical, or financial information.
Market read
Traders may monitor for follow-on insider activity, but the 10b5-1 framing typically reduces immediate price impact expectations.
What to watch
The filing confirms execution price ($75) and remaining holdings (52,173 shares), but does not indicate whether future tranches will accelerate or whether there are concurrent buys/sales by other insiders.
Background
The article is an SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine insider Khara Rahul (Chief Legal Officer) sold $187,500 of IRON stock via a Rule 10b5-1 plan at $75/share (Form 4).
Likely minimal near-term impact; any effect would be sentiment-only rather than fundamental.
The filing is a Form 4 insider transaction with stated pre-arranged 10b5-1 plan; it discloses sale size, dates, and $75/share execution without any new company fundamentals.
Market effects
No sector read-through; this is company-specific insider liquidity disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is pre-arranged under 10b5-1, it may be less informative than discretionary selling; traders may ignore it unless paired with other negative catalysts.
Key entities
- public_companyIRON
Disc Medicine, Inc.; subject of the Form 4 insider sale disclosure.
- insiderKhara Rahul
Chief Legal Officer who sold 2,500 shares at $75/share under a Rule 10b5-1 plan.